SCHEMBL15097037

SCHEMBL15097037

CN(c1ccccc1)c1ccc2c(c1)-c1ccc3c4cccc5cccc(c6ccc-2c1c63)c54

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 4/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 3/20 0.39
HPGD P15428 3/20 0.39
CASP1 P29466 2/20 0.39
HIF1A Q16665 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PDK2 Q15119 1/20 0.37
TP53 P04637 1/20 0.36
CASP7 P55210 1/20 0.36
CYP1A2 P05177 2/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
ITK Q08881 1/20 0.36
PDE5A O76074 2/20 0.35
KDR P35968 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15097043 0.85 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL15097036 0.85 ALDH1A1 (0.40) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL12200311 0.83 ALDH1A1 (0.40) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL15097039 0.82 PDE5A (0.36) ALDH1A1MAPK1HPGDPDK2TP53
SCHEMBL15097044 0.80 ALDH1A1 (0.36) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL15097040 0.80 CYP1A2 (0.43) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL25693538 0.78 PDK2 (0.53) ALDH1A1MAPK1HPGDL3MBTL1PDK2
SCHEMBL15097048 0.78 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL15097045 0.78 CYP1A2 (0.41) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL14673547 0.76 ALDH1A1 (0.61) ALDH1A1HSD17B10TSHRMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130174910-A1 INDENOPERYLENE COMPOUND, MATERIAL FOR ORGANIC THIN-FILM PHOTOVOTAIC CELL CONTAINING INDENOPERYLENE DERIVATIVE AND ORGANIC THIN FILM PHOTOVOTAIC CELL USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-07-11 US disclosed
US-20130174910-A1 INDENOPERYLENE COMPOUND, MATERIAL FOR ORGANIC THIN-FILM PHOTOVOTAIC CELL CONTAINING INDENOPERYLENE DERIVATIVE AND ORGANIC THIN FILM PHOTOVOTAIC CELL USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130174910-A1 INDENOPERYLENE COMPOUND, MATERIAL FOR ORGANIC THIN-FILM PHOTOVOTAIC CELL CONTAINING INDENOPERYLENE DERIVATIVE AND ORGANIC THIN FILM PHOTOVOTAIC CELL USING SAME CCNT1, STRA6, CCNA2 ALDH1A1 504/4885HSD17B10 3593/4885TSHR 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.